Menu
Currency
GWAS Study

Asthma exacerbations and eosinophilia in the UK Biobank: a genome-wide association study.

Edris A, Voorhies K, Lutz SM et al.

38196893 PubMed ID
GWAS Study Type
57421 Participants
57 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

EA
Edris A
VK
Voorhies K
LS
Lutz SM
IC
Iribarren C
HI
Hall I
WA
Wu AC
TM
Tobin M
FK
Fawcett K
LL
Lahousse L
Chapter II

Abstract

Summary of the research findings

Asthma exacerbations reflect disease severity, affect morbidity and mortality, and may lead to declining lung function. Inflammatory endotypes (e.g. T2-high (eosinophilic)) may play a key role in asthma exacerbations. We aimed to assess whether genetic susceptibility underlies asthma exacerbation risk and additionally tested for an interaction between genetic variants and eosinophilia on exacerbation risk.

11,604 European ancestry cases, 37,890 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

57421
Total Participants
GWAS
Study Type
Yes
Replicated
7,927 European ancestry individuals
Replication Participants
European
Ancestry
U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.